Evidence map›Paper›PMID 35707770›Full record

ArticleGlobal medical genetics2022

Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease.

Sercan Kenanoglu, Nefise Kandemir, Hilal Akalin, Nuriye Gokce, Mehmet F Gol, Murat Gultekin, Emel Koseoglu, Meral Mirza, Munis Dundar

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global medical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sercan KenanogluDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Nefise KandemirDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Hilal AkalinDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Nuriye GokceDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Mehmet F GolDepartment of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Murat GultekinDepartment of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Emel KoseogluDepartment of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Meral MirzaDepartment of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Munis DundarDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Erciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that is characterized by a devastating decline in cognitive activities among all types of dementia, and it severely affects the quality of life. Late-onset AD (LOAD) occurs after the age of 65 years and develops sporadically. Although aging comes first along the main risk factors underlying LOAD, disease-causing susceptibility genes have been associated with disease pathogenesis. In our study, we included the genes

Indexed as

DRD3HS1BP3HTRA2PARP1POLBSLC1A2

Identifiers

PMID35707770
PMCPMC9192179
OpenAlexW4220887783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.